Search

Your search keyword '"Borella, M"' showing total 65 results
Start Over Author "Borella, M" Publication Type Electronic Resources
65 results on '"Borella, M"'

1. The cognitive rehabilitation in Alzheimer's disease: a proposal for home-based model

Author

Grassi, M, Perin, C, Borella, M, Grassi, MP, Borella, M., PERIN, CECILIA, Grassi, M, Perin, C, Borella, M, Grassi, MP, Borella, M., and PERIN, CECILIA

Abstract

Scopo: verificare l'efficacia di un programma riabilitativo cognitivo domiciliare in pazienti con malattia di Alzheimer, in termini di miglioramento sia delle performance cognitive-comportamentali che delle attività della vita quotidiana. Metodi: sono stati arruolati pazienti affetti da probabile AD; i pazienti e i familiari con buona compliance venivano arruolati nel 'gruppo riabilitativo'(GR), quelli senza tale compliance costituivano il 'gruppo di controllo' (GC). I soggetti al tempo basale (T0) sono stati sottoposti a test neuropsicologici (MMSE) ed a scale di daily -living (IADL) e comportamentali (NPI). I soggetti GR venivano addestrati con un familiare all'uso di un eserciziario per il training cognitivo domiciliare quotidiano. Dopo 12 settimane tutti i pazienti venivano sottoposti a MMSE , IADL, e NPI. Risultati:sono stati arruolati 10 soggetti in entrambi i gruppi con caratteristiche generali omogenee. Il confronto relativo alle medie dei parametri cognitivo-funzionali non hanno evidenziato differenze significative al tempo basale. Dopo il periodo di trattamento riabilitativo (T1) GR ha evidenziato , rispetto a GC, un miglioramento in MMSE e NPI e in GC un peggioramento di NPI. Conclusioni: l'intervento riabilitativo cognitivo domiciliare sembra influenzare in modo positivo le performance cognitive con una successiva ricaduta anche sul parametro comportamentale e di daily-living. il rilievo di una efficacia della riabilitazione cognitiva in AD ripropone l'importanza di affrontare in termini metodologici e strumentali controllati questo tipo di intervento., Aim. This clinical study aims at assessing the efficacy of a home cognitive rehabilitation program for Alzheimer Disease patients, evaluating the improvement in cognitive-behavioural performances and daily living activities. Methods. Patients who reported a good compliance to cognitive rehabilitation were assigned to the “rehabilitated group” (GR), and those patients with poor compliance were enrolled in the “control group” (GC). 10 patients were respectively enrolled in the GR and the GC. At the basal time (T0) all patients underwent a comprehensive neuropsychological assessment including psychometric tests (MMSE) as well as daily living (IADL) and behavioural (NPI) questionnaires. GR subjects were instructed to use an ad hoc designed exercise book for their daily home cognitive training, which needs the help of relatives. After 12 weeks (T1) all patients underwent re-evaluations. Results. Patients enrolled in the GR and the GC had homogeneous characteristics with respect to age, gender, education and disease duration. At baseline, the cognitive and functional parameters did not show any statistically significant difference between the two groups. After cognitive rehabilitation (T1) GR showed, in respect to GC, a significant statistical improvement in MMSE and IADL; the analysis pre-post rehabilitation showed an improvement in MMSE and NPI for GR and a worsening in NPI for GC. Conclusion. The home cognitive rehabilitation seems to have a positive influence on cognitive performances with an effective rebound on behaviour and daily living activities in Alzheimer disease patients. These findings need to be replicated in a larger randomized controlled trial.

Published
2008

9. Cognitive training in MCI

Author

Grassi, M, Perin, C, Borella, M, Grassi, MP, Borella, M., PERIN, CECILIA, Grassi, M, Perin, C, Borella, M, Grassi, MP, Borella, M., and PERIN, CECILIA

Published
2006

17. The cerebellar cognitive-affective syndrome

Author

Grassi, M, Perin, C, Borella, M, Grassi, MP, Borella, M., PERIN, CECILIA, Grassi, M, Perin, C, Borella, M, Grassi, MP, Borella, M., and PERIN, CECILIA

Published
2004

22. Clinical Aspects of the AIDS dementia-Complex in Relation to Histopathological and Immunohistochemical variables

Author

Grassi, M, Clerici, F, Vago, L, Perin, C, Borella, M, Nebuloni, M, Moroni, M, Mangoni, A, Grassi,MP, Clerici,F, Vago,L, Borella,M, Nebuloni,M, Moroni,M, Mangoni,A, PERIN, CECILIA, Grassi, M, Clerici, F, Vago, L, Perin, C, Borella, M, Nebuloni, M, Moroni, M, Mangoni, A, Grassi,MP, Clerici,F, Vago,L, Borella,M, Nebuloni,M, Moroni,M, Mangoni,A, and PERIN, CECILIA

Abstract

to correlate cerebral histopathological and immunohistochemical changes in the neuroclinical features of the AIDS dementia complex(ADC), autopsy results of 28 ADC patients were related, in a retrospective analysis, to scores on a standardised neurological examination performed at neurological onset. from a histopathological point of view, the cases were classified as follows: 9 cases of HIV leucoencephalopathy (HIVL; diffuse myelin damage and rare microglial nodules), 7 cases of HIV encephalitis (HIVE; several microglial nodules and no myelin damage) and 12 cases of mixed HIVL and HIVE (HIVL-E). The groups differed significantly with respect to symptoms and CD4 count at neurological onset, survival and neurological impairment. Immunohistochemically, the interstitial component (p-24-positive cells scattered singly within the white matter) was significantly more prevalent in HIVL, and the micronodular component (P24-positive cells confined within microglial nodules) in HIVE. Neurological damage was worse in cases with a high prevalence of interstitial component or a low prevalence of micronodular component. HIVE, HIVL, and HIVL-E are distinct clinical forms of ADC. Neurological impairmente is related to white matter damage.

Published
2002

23. Hemifacial spasm in benign intracranial hypertension

Author

Grassi, M, Carella, F, Perin, C, Borella, M, Grassi,MP, Carella,F, Borella,M, PERIN, CECILIA, Grassi, M, Carella, F, Perin, C, Borella, M, Grassi,MP, Carella,F, Borella,M, and PERIN, CECILIA

Published
2001

25. Effetto della tossicodipendenza (TD) sull'AIDS Dementia Complex(ADC)

Author

Grassi, M, Perin, C, Borella, M, Clerici, F, Zocchetti, C, D'arminio Monforte, A, Mangoni, A, Grassi,MP, Borella,M, Clerici,F, Zocchetti,C, D'arminio Monforte,A, Mangoni,A, PERIN, CECILIA, Grassi, M, Perin, C, Borella, M, Clerici, F, Zocchetti, C, D'arminio Monforte, A, Mangoni, A, Grassi,MP, Borella,M, Clerici,F, Zocchetti,C, D'arminio Monforte,A, Mangoni,A, and PERIN, CECILIA

Published
1997

26. Sindrome di Foix-Chavany-Marie in due soggetti affetti da AIDS

Author

Grassi, M, Perin, C, Borella, M, Clerici, F, Nasuelli, D, D'Arminio Monforte, A, Mangoni, A, Grassi,MP, Borella,M, Clerici,F, Nasuelli,D, D'Arminio Monforte,A, Mangoni,A, PERIN, CECILIA, Grassi, M, Perin, C, Borella, M, Clerici, F, Nasuelli, D, D'Arminio Monforte, A, Mangoni, A, Grassi,MP, Borella,M, Clerici,F, Nasuelli,D, D'Arminio Monforte,A, Mangoni,A, and PERIN, CECILIA

Published
1997

27. Deficit Neuropsicologici secondari a lesioni focali cerebrali in soggetti HIV sieropositivi

Author

Grassi, M, Perin, C, Borella, M, Clerici, F, Nasuelli, D, d'Arminio Monforte, A, Mangoni, A, Grassi,MP, Borella,M, Clerici,F, Nasuelli,D, d'Arminio Monforte,A, Mangoni,A, PERIN, CECILIA, Grassi, M, Perin, C, Borella, M, Clerici, F, Nasuelli, D, d'Arminio Monforte, A, Mangoni, A, Grassi,MP, Borella,M, Clerici,F, Nasuelli,D, d'Arminio Monforte,A, Mangoni,A, and PERIN, CECILIA

Published
1997

28. Soggetti HIV sieropositivi neurologicamente asintomatici: influenza dei livelli di CD4 sulle performance cognitive

Author

Grassi, M, Perin, C, Borella, M, Clerici, F, Zocchetti, C, D'Arminio Monforte, A, Mangoni, A, Grassi,MP, Borella,M, Clerici,F, Zocchetti,C, D'Arminio Monforte,A, Mangoni,A, PERIN, CECILIA, Grassi, M, Perin, C, Borella, M, Clerici, F, Zocchetti, C, D'Arminio Monforte, A, Mangoni, A, Grassi,MP, Borella,M, Clerici,F, Zocchetti,C, D'Arminio Monforte,A, Mangoni,A, and PERIN, CECILIA

Published
1997

29. the Wisconsin card sorting test(WCST) in Alzheimer 's disease (AD) amd parkinson's disease (PD): comparison between four modality of evaluation

Author

Grassi, M, Perin, C, Borella, M, Clerici, F, Zocchetti, C, Mangoni, A, Grassi,MP, Borella,M, Clerici,F, Zocchetti,C, Mangoni,A, PERIN, CECILIA, Grassi, M, Perin, C, Borella, M, Clerici, F, Zocchetti, C, Mangoni, A, Grassi,MP, Borella,M, Clerici,F, Zocchetti,C, Mangoni,A, and PERIN, CECILIA

Abstract

The WCST is considered a fiontal lest, mainly suitable tu evaluate aspects of 'problem solving'. The several evaluation criteria are due to the different modalities of the test used in the neuropsychological field. AIM: to consider some modalities of the test in order to define which could offer more informations when applied to two degenerative pathologies: PD and AD. METHODS: The modalities proposed by Grant-Berg(GB), Milner(M), Taylor(T) and Heaton(H) have been chosen. 44 AD pts and 31 PD pts have been enrolled For each patient two control subjects with the same age, have been chosen among 546 sbjs.(S) enrolled to obtain the WCST's normal values. The parameters(prt) St(stages), Rc( corrected answers). El( total errors), Ep(perseverative errors), Enp(non perseverative errors), U( 'special' answers) were considered for GB,M and T. In addition to the above mentioned prt, the following were considered for H too. Rp( perseverative answers), %Ep(% of perseverative errors), NTPS( cards to complete the first St). CLR and %CLR ( nc and % of answers of conceptual level), FMS (failure to mantain the set) and I Tl. (learning to learn measure) The statistical analysis requires the study of the frequency distribution, indicator of central tendency, indicator of dispersion, analysis of variance. RESULTS 1)AD vs S: AD performance was statistically worse in the following prt:-St(in all modalities);-Rc(in T and M);-U(in T, M, GB ): -Enp (inH) ;-Et (inT.M andH);-NTPS,CLR,%CLR inH. 2)PD vs S no differences were found in the four modalities. The analysis of the patients divided according to a therapeutic criteria(14 pts with a<1? mnths and 17 pts with a >12 mnths L-dopa therapy) has shown a worse statistically significant performance for the prt St(in T and H) and Rp,Ep,%Ep,%CLR in H in longer therapy pts. DISCUSSION: the GB modality is more applicable in AD and the H more useful in PD.

Published
1997

30. a new tool for the dementia screening in AIDS patients:HIVDA (HIV Dementia Assessment)

Author

Grassi, M, Perin, C, Clerici, F, Borella, M, D'arminio Monforte, A, Zocchetti, C, Moroni, M, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, D'arminio Monforte,A, Zocchetti,C, Moroni,M, Mangoni,A, PERIN, CECILIA, Grassi, M, Perin, C, Clerici, F, Borella, M, D'arminio Monforte, A, Zocchetti, C, Moroni, M, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, D'arminio Monforte,A, Zocchetti,C, Moroni,M, Mangoni,A, and PERIN, CECILIA

Abstract

A screening dementia scale is very useful for: -ADC early diagnosis; -ADC follow-up (in relation to the pharmachological therapy). AIM: to verify the suitability of HIVDA. METHODS: from 1.3 to 31.12 1996 HIV+ pts in all stages of the illness were enrolled satisfying the defined inclusion criteria. These pts underwent a wide and complete neuropsychological evaluation and neurological examination in order to classify them under the following diagnosis. Moderate Dementia (MD) and Severe Dementia (SD) according to the criteria of the AAN .Border-Line(BL) and Normal(N). The pts were then evaluated by another examiner unaware of the previous neuropsychological diagnosis with the HIVDA which is composed of two parts: the anamnestic part (AP1 and AP2) and the psychometric part (PP) HIVDA scale is the result of a step by step implementation from the Blessed scale. RESULTS: 153 pts were enrolled. 68 were classified as N, 24 as BL, 26 as MD, 35 as SD. CD4 number was the only statistically different data among the general characteristics . HIVDA A and P total scores are the following: N BL MD SD HIVDA Ax(sd) 2.80(202) 6.34(4.24) 8.03(4.66) 13.00(4.01)HIVDA P 33.78(314)30.07(2.72)27.66(3.60)19.26(4.28) p<0.0001 HIVDA A (A1 anamnestic, A2 behavioral) and P( information, memory, concentration, frontal functions) subitems show a statistically difference too DISCUSSION HIVDA seems to point out scores that agree with the neuropsychological diagnosis: such scores look quite precise both in BL case and in dementia grading. These results confirm the utility to compute the sensitivity, specificity and predictive values of this scale.

Published
1997

31. HIVDA(HIV dementia Assessment): scala di valutazione per la demenza HIV correlata

Author

Grassi, M, Perin, C, Borella, M, d'Arminio Monforte, A, Zocchetti, C, Mangoni, A, Grassi,MP, Borella,M, d'Arminio Monforte,A, Zocchetti,C, Mangoni,A, PERIN, CECILIA, Grassi, M, Perin, C, Borella, M, d'Arminio Monforte, A, Zocchetti, C, Mangoni, A, Grassi,MP, Borella,M, d'Arminio Monforte,A, Zocchetti,C, Mangoni,A, and PERIN, CECILIA

Published
1996

32. Encefalite da CMV: varianti anatomo-patologiche e quadri clinici corrispondenti

Author

Grassi, M, Clerici, F, Perin, C, D'Arminio Monforte, A, Vago, L, Borella, M, Boldorini, R, Mangoni, A, Grassi,MP, Clerici,F, D'Arminio Monforte,A, Vago,L, Borella,M, Boldorini,R, Mangoni,A, PERIN, CECILIA, Grassi, M, Clerici, F, Perin, C, D'Arminio Monforte, A, Vago, L, Borella, M, Boldorini, R, Mangoni, A, Grassi,MP, Clerici,F, D'Arminio Monforte,A, Vago,L, Borella,M, Boldorini,R, Mangoni,A, and PERIN, CECILIA

Published
1996

33. HIV encephalitis and HIV leukoencephalopathy are associated with distint clinical and radiological subtypes of the AIDS dementia complex

Author

Grassi, M, Clerici, F, Boldorini, R, Perin, C, Vago, L, D'Arminio Monforte, A, Borella, M, Nebuloni, M, Mangoni, A, Grassi,MP, Clerici,F, Boldorini,R, Vago,L, D'Arminio Monforte,A, Borella,M, Nebuloni,M, Mangoni,A, PERIN, CECILIA, Grassi, M, Clerici, F, Boldorini, R, Perin, C, Vago, L, D'Arminio Monforte, A, Borella, M, Nebuloni, M, Mangoni, A, Grassi,MP, Clerici,F, Boldorini,R, Vago,L, D'Arminio Monforte,A, Borella,M, Nebuloni,M, Mangoni,A, and PERIN, CECILIA

Published
1996

34. What is hidden under ADC term?

Author

Grassi, M, Clerici, F, Perin, C, Boldorini, R, D'Arminio Monforte, A, Borella, M, Mangoni, A, Grassi,MP, Clerici,F, Boldorini,R, D'Arminio Monforte,A, Borella,M, Mangoni,A, PERIN, CECILIA, Grassi, M, Clerici, F, Perin, C, Boldorini, R, D'Arminio Monforte, A, Borella, M, Mangoni, A, Grassi,MP, Clerici,F, Boldorini,R, D'Arminio Monforte,A, Borella,M, Mangoni,A, and PERIN, CECILIA

Published
1996

37. Clinical criteria to distinguish cytomegalovirus encephalitis (CMVE) from HIV encephalitis (HIVE)

Author

Grassi, M, Clerici, F, Perin, C, Borella, M, Boldorini, R, d'Arminio Monforte, A, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Boldorini,R, d'Arminio Monforte,A, Mangoni,A, PERIN, CECILIA, Grassi, M, Clerici, F, Perin, C, Borella, M, Boldorini, R, d'Arminio Monforte, A, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Boldorini,R, d'Arminio Monforte,A, Mangoni,A, and PERIN, CECILIA

Published
1995

39. Study on the applicability of the modified Blessed scale in HIV positive subjects with and without cognitive deficits and its correlations with histopathological data

Author

Grassi, M, Clerici, F, Perin, C, Borella, M, Zocchetti, C, Vago, L, D'Arminio, M, A, M, M, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Vago,L, d'Arminio Monforte, A, Moroni, Mangoni,A, PERIN, CECILIA, Grassi, M, Clerici, F, Perin, C, Borella, M, Zocchetti, C, Vago, L, D'Arminio, M, A, M, M, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Vago,L, d'Arminio Monforte, A, Moroni, Mangoni,A, and PERIN, CECILIA

Published
1995

40. Cognitive functions related to HIV seropositive satus and drug abuse

Author

Grassi, M, Perin, C, Clerici, F, Zocchetti, C, Borella, M, Cargnel, A, Mangoni, A, Grassi,MP, Clerici,F, Zocchetti,C, Borella,M, Cargnel,A, Mangoni,A, PERIN, CECILIA, Grassi, M, Perin, C, Clerici, F, Zocchetti, C, Borella, M, Cargnel, A, Mangoni, A, Grassi,MP, Clerici,F, Zocchetti,C, Borella,M, Cargnel,A, Mangoni,A, and PERIN, CECILIA

Published
1995

41. Clues for differential diagnosis between HIV leukoencephalopathy (HIVL) and progressive multifocal Leukoencephalopathy(PML)

Author

Grassi, M, Clerici, F, Perin, C, Borella, M, Boldorini, R, Vago, L, d'Arminio Monforte, A, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Boldorini,R, Vago,L, d'Arminio Monforte,A, Mangoni,A, PERIN, CECILIA, Grassi, M, Clerici, F, Perin, C, Borella, M, Boldorini, R, Vago, L, d'Arminio Monforte, A, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Boldorini,R, Vago,L, d'Arminio Monforte,A, Mangoni,A, and PERIN, CECILIA

Published
1994

42. HIV encephalopathy: two different clinical forms

Author

Grassi, M, Clerici, F, Perin, C, Borella, M, Boldorini, R, d'Arminio monforte, A, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Boldorini,R, d'Arminio monforte,A, Mangoni,A, PERIN, CECILIA, Grassi, M, Clerici, F, Perin, C, Borella, M, Boldorini, R, d'Arminio monforte, A, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Boldorini,R, d'Arminio monforte,A, Mangoni,A, and PERIN, CECILIA

Published
1994

43. HIV encephalopathy: two different clinical forms

Author

Grassi, M, Clerici, F, Perin, C, Borella, M, Boldorini, R, d'Arminio monforte, A, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Boldorini,R, d'Arminio monforte,A, Mangoni,A, PERIN, CECILIA, Grassi, M, Clerici, F, Perin, C, Borella, M, Boldorini, R, d'Arminio monforte, A, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Boldorini,R, d'Arminio monforte,A, Mangoni,A, and PERIN, CECILIA

Published
1994

44. Clues for differential diagnosis between HIV leukoencephalopathy (HIVL) and progressive multifocal Leukoencephalopathy(PML)

Author

Grassi, M, Clerici, F, Perin, C, Borella, M, Boldorini, R, Vago, L, d'Arminio Monforte, A, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Boldorini,R, Vago,L, d'Arminio Monforte,A, Mangoni,A, PERIN, CECILIA, Grassi, M, Clerici, F, Perin, C, Borella, M, Boldorini, R, Vago, L, d'Arminio Monforte, A, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Boldorini,R, Vago,L, d'Arminio Monforte,A, Mangoni,A, and PERIN, CECILIA

Published
1994

45. Cytomegalovirus (CMV) cerebral infections: evaluation of different clinical pictures

Author

Grassi, M, Clerici, F, Perin, C, Borella, M, Boldorini, R, d'Arminio monforte, A, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Boldorini,R, d'Arminio monforte,A, Mangoni,A, PERIN, CECILIA, Grassi, M, Clerici, F, Perin, C, Borella, M, Boldorini, R, d'Arminio monforte, A, Mangoni, A, Grassi,MP, Clerici,F, Borella,M, Boldorini,R, d'Arminio monforte,A, Mangoni,A, and PERIN, CECILIA

Published
1994

46. HIV infection and drug abuse: influence on cognitive functions

Author

Grassi, M, Clerici, F, Perin, C, Zocchetti, C, Borella, M, Cargnel, A, Mangoni, A, Grassi,MP, Clerici,F, Zocchetti,C, Borella,M, Cargnel,A, Mangoni,A, PERIN, CECILIA, Grassi, M, Clerici, F, Perin, C, Zocchetti, C, Borella, M, Cargnel, A, Mangoni, A, Grassi,MP, Clerici,F, Zocchetti,C, Borella,M, Cargnel,A, Mangoni,A, and PERIN, CECILIA

Published
1994

48. MCI and Rehabilitation Feasibility Criteria

Author

Grassi, M, Perin, C, Clerici, M, Borella, M, Mariani, C, Grassi, MP, Mariani, C., PERIN, CECILIA, Grassi, M, Perin, C, Clerici, M, Borella, M, Mariani, C, Grassi, MP, Mariani, C., and PERIN, CECILIA

Published
2005

49. Cognitive deficits in Fahr's disease

Author

Grassi, M, Perin, C, Borella, M, Pederzoli, M, Grassi, MP, Pederzoli, M., PERIN, CECILIA, Grassi, M, Perin, C, Borella, M, Pederzoli, M, Grassi, MP, Pederzoli, M., and PERIN, CECILIA

Published
2005

50. Le patologie del Sistema nervoso Centrale e Periferico da abuso e dipendenza da oppiacei e cocaina

Author

Borella, M, Grassi, M, Mangoni, A, Perin, C, Grassi, MP, PERIN, CECILIA, Borella, M, Grassi, M, Mangoni, A, Perin, C, Grassi, MP, and PERIN, CECILIA

Abstract

In questo capitolo gli autori, oltre che elencare le principali conseguenze dell’uso e abuso di sostanze tossiche sul funzionamento del sistema nervoso centrale e periferico, riportano la sintesi delle loro osservazioni pubblicate in ambito internazionale circa gli effetti della tossicodipendenza e della sieropositività HIV sulle funzioni cognitive superiori. LE PATOLOGIE NEUROLOGICHE DA ABUSO E DIPENDENZA DA COCAINA: l’uso di cocaina abbassa la soglia di scatenamento di una crisi epilettica in soggetti già predisposti. Le crisi indotte sono in genere singole, generalizzate e sono indotte dall’assunzione di crack o uso e.v. Complicanze cerebrovascolari da uso e abuso: eventi emorragici cerebrali. Meno frequenti: neuropatia ottica, sindromi extrapiramidali ed eventi psico-organici . LE PATOLOGIE NEUROLOGICHE DA USO E DIPENDENZA DI OPPIACEI: l’overdose di eroina conduce al coma con depressione respiratoria, tachicardia, miosi e talora crisi comiziali. Numerose sono le complicanze infettive e non infettive da uso. Le prime sono legate all’inoculazione e.v. di materiale contaminato, le seconde sono legate all’ipossia e all’ipotensione prodotte dall’overdose. Numerose le complicanze del SNP sia nervo che muscolo (poliradicolonevriti, plessiti, rabdomiolisi ecc) PATOLOGIE NEUROLOGICHE NEL SOGGETTO TOSSICODIPENDENTE HIV POSITIVO: si riporta la sintesi del contributo scientifico degli autori del presente capitolo allo studio della compromissione delle funzioni cognitive nella popolazione HIV+TD+. In particolare si illustrano i risultati emersi da una serie di osservazioni fatte su tale popolazione confrontata con soggetti HIV- TD+ e HIV- TD- e HIV+ TD- da cui è emerso il ruolo della tossicodipendenza sulle performance cognitive , la influenza di un uso attuale rispetto ad uno pregresso , la influenza di un uso attuale rispetto al pregresso anche su parametri neurologici ( ROT, tremore posturale, coordinazione). Si analizzano poi i fattori di rischio della sieropositivita

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results